Evidence map›Paper›PMID 35505391›Full record

ArticleAntimicrobial resistance and infection control2022

Baseline study for improving diagnostic stewardship at secondary health care facilities in Nigeria.

Abiodun Egwuenu, Adaora Ejikeme, Sara Tomczyk, Anja von Laer, Olaniyi Ayobami, Oluwaseun Odebajo, Samuel Akhibi, Constance Agulanna, Osayande Osagie, Ugochi Stellamaris Inweregbu and 8 more

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Abiodun Egwuenu *Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria. abiodun.egwuenu@ncdc.gov.ng.ORCID 0000-0002-9369-4771
Adaora Ejikeme *Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria. rosemaryejikeme@yahoo.com.ORCID 0000-0001-9919-3284
Sara TomczykDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0001-6975-2663
Anja von LaerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-4010-1714
Olaniyi AyobamiDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-1480-386X
Oluwaseun OdebajoPrevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
Samuel AkhibiMedical Laboratory Unit, Maitama District Hospital, Abuja, Federal Capital Territory, Nigeria.
Constance AgulannaBwari General Hospital, Bwari, Federal Capital Territory, Nigeria.
Osayande OsagieBwari General Hospital, Bwari, Federal Capital Territory, Nigeria.
Ugochi Stellamaris InweregbuPrevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0001-7944-9457
Ridwan YahayaPrevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
Tochi OkworPrevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0003-2391-7770
Hannah Dada-AdegbolaCollege of Medicine, University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.ORCID 0000-0002-9566-8585
Ikeoluwapo AjayiDepartment of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.ORCID 0000-0001-7719-8746
Abdulhakeem OlorukoobaDepartment of Community Medicine, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.ORCID 0000-0001-9067-9819
Tim EckmannsDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Chinwe Lucia OchuPrevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0002-0630-7332
Chikwe IhekweazuPrevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0003-0659-0833
Nigeria Centre for Disease Control · NGRobert Koch Institute · DEFederal Medical Centre · NGUniversity of Ibadan · NGAhmadu Bello University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood culture diagnostics are critical tools for sepsis management and antimicrobial resistance (AMR) surveillance. A baseline study was conducted to assess reported sepsis case finding, blood culture diagnostics, antimicrobial susceptibility testing (AST) and antimicrobial use at secondary health care facilities to inform the development of diagnostic stewardship improvement strategies in Nigeria.

methodsA cross-sectional online survey was conducted among 25 public secondary health care facilities in Abuja, Federal Capital Territory (FCT) and Lagos State in Nigeria to evaluate the capacity for pathogen identification and AST. Data were then prospectively extracted on all patients with reported suspected sepsis from electronic medical records from selected departments at two facilities in the Federal Capital Territory from October 2020 to May 2021 to further assess practices concerning sepsis case-finding, clinical examination findings, samples requested, and laboratory test results. Data were descriptively analysed, and a multivariate logistic regression analysis was conducted to determine factors associated with blood culture requests.

resultsIn the online survey, 32% (8/25) of facilities reported performing blood cultures. Only one had access to a clinical microbiologist, and 28% (7/25) and 4% (1/25) used standard bacterial organisms for quality control of media and quality control strains for AST, respectively. At the two facilities where data abstraction was performed, the incidence of suspected sepsis cases reported was 7.1% (2924/41066). A majority of these patients came from the paediatrics department and were outpatients, and the median age was two years. Most did not have vital signs and major foci of infection documented. Blood cultures were only requested for 2.7% (80/2924) of patients, of which twelve were positive for bacteria, mainly Staphylococcus aureus. No clinical breakpoints were used for AST. Inpatients (adjusted odds ratio [aOR]: 7.5, 95% CI: 4.6-12.3) and patients from the urban health care facility (aOR:16.9, 95% CI: 8.1-41.4) were significantly more likely to have a blood culture requested.

conclusionLow blood culture utilisation remains a key challenge in Nigeria. This has implications for patient care, AMR surveillance and antibiotic use. Diagnostic stewardship strategies should focus on improving access to clinical microbiology expertise, practical guidance on sepsis case finding and improving blood culture utilisation and diagnostics.

Indexed as

Anti-Infective AgentsSepsisAnti-Bacterial AgentsBacteriaChildChild, PreschoolCross-Sectional StudiesDelivery of Health CareHumansNigeriaAnti-Bacterial AgentsAnti-Infective AgentsAntibiotic useBlood cultureDiagnostic stewardshipNigeriaSepsis

Identifiers

PMID35505391
PMCPMC9066975
OpenAlexW4225299270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.